Advertisement
News
Advertisement

FDA green-lights NeuroMetrix pain treatment device for bed-time use

Fri, 07/12/2013 - 1:36pm
Mass Device

NeuroMetrix wins FDA clearance to market its Sensus neurostimulation device for pain management during sleep.

NeuroMetrix's Sensus

NeuroMetrix's (NSDQ:NURO) Sensus wearable pain management device can now be paired with pajamas thanks to the FDA's clearance of the device for use during sleep.

The FDA typically requires warning labels for transcutaneous electrical nerve stimulators like Sensus because of their tendency to dislodge during sleep, which may pose an electrical hazard. NeuroMetrix says its Sensus system features a risk-assessment algorithm that mitigates that risk.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading